Shree Tirupati (TIRUPATI)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding of 66.15% aligns owner interests with minority shareholders.
• ROCE of 15.53% indicates decent existing capital efficiency, though at risk from declining sales.
• Latest quarter sales of ₹94 Cr shows meaningful operational scale.
• No dividend obligation preserves cash for operations or debt reduction.

Concerns

• Profit growth down 73.62% and sales down 10.38% reflect severe earnings deterioration.
• P/E of 58.06 is expensive against collapsing profits, leaving no margin of safety.
• Piotroski F-Score of 3/9 signals weak financial and operational health.
• Zero dividend yield provides no income support while investors wait for recovery.

AI Analysis

At ₹470, Shree Tirupati is capitalized at ₹531 Cr. This is not a wonderful company at a fair price; it is a cyclical industrial plastics business in a clear downturn. Sales have declined 10.38%, and profits have collapsed 73.62%. The latest quarter tells the same story: ₹94 Cr of revenue produced only ₹2 Cr of net profit, a margin of roughly 2%. Paying a P/E of 58.06 for that kind of earnings power is dangerous, especially when the trend is downward. Graham would demand a margin of safety; today the market offers none. The Piotroski F-Score of 3/9 reinforces my caution—this is a red flag on the balance sheet and operations. ROCE of 15.53% is respectable, but with shrinking sales and deteriorating profits, that return is likely to erode. There is zero dividend to compensate while waiting. The 52-week range of ₹337.80 to ₹893.00 shows severe volatility; at ₹470 the stock sits roughly half its high. Promoter holding of 66.15% is positive—owners share the pain—but high holding is not a moat. Industrial plastics face competition and cyclical demand; I see no durable pricing power in these numbers. This is a cyclical at the wrong stage being priced like a growth stock. I would not buy. I need evidence that sales stabilize, margins recover, and returns stop falling before I revisit. Until then, the risk/reward is poor.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer